$ALT (+1,65%) is now performing again after the last trial report and crash.

Of course, there is a lot of risk at this early stage.

Let's see how the FDA sees it later on.

Current developments against:

* Obesity and its associated diseases

* MASH (Metabolic Dysfunction-Associated Steatohepatitis)

* Alcohol use disorder (AUD)

* Alcohol-Associated Liver Disease (ALD)

Earnings next week (11.11 - 15.11)

$SHOP (-0,33%)

$SOUN

$MARA (+1,27%)

$BABA (+2,97%)

$CAVA

$SPOT (-4,02%)

$AMAT (-0,69%)

$DIS (-1,83%)

$PLUG (+4,92%)

$HD (-0,38%)

$MNDY (-1,82%)

$OXY (+0,76%)

$RKLB (-4,38%)

$BSEM

$ZETA (-1,62%)

$SE (+0%)

$RKT

$CSCO (-0,28%)

$ASTS (-2,62%)

$WULF (-1,73%)

$ONON (+1,41%)

$OKLO

$HUT (-1,15%)

$NVAX (-1,65%)

$HTZ (-3,3%)

$LUNR

$CART

$TALN

$BITF (+1,02%)

$GRAB (+0,65%)

$JD (+4,08%)

$LAZR

$ALT (+1,65%)

$CRON (+0,29%)

$ICL

$NICE

$CYBR (+0,03%)

$BXSL (-0,71%)

$DESP

$ARMK (-0,35%)

$TSN (-0,78%)

$RUM

$PGY

$TGI

$AAP (-0,44%)

$AXSM (-0,46%)

$AZN (-0,42%)

$BILI (+3,3%)

$LINC (+0,9%)

$LQDA (-0,56%)

Hi, could I have your opinions on $ALT (+1,65%) share?

$ALT (+1,65%) I hope things are looking up😂

$ALT (+1,65%) What do you think of the share?

The share is very exciting and after the drop I am now hoping for a nice return of 20%-30%